Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Hepatitis C

Free Subscription 03.12.2018 1 Enferm Infecc Microbiol Clin 4 J Hepatol 1 J Infect Dis 1 J Virol 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Enferm Infecc Microbiol Clin

1. MARTIN-CARBONERO L, Dominguez-Dominguez L, Bailon L, Torres R, et al
   Effect of mono/dual antiretroviral therapy on suppression of HCV and HIV during treatment of HCV infection in HIV/HCV-coinfected patients.
   Enferm Infecc Microbiol Clin. 2018 Nov 23. pii: S0213-005X(18)30277.
   PubMed     Text format     Abstract available
   
   

   
   J Hepatol

2. MODIN L, Arshad A, Wilkes B, Benselin J, et al
   Epidemiology and natural history of hepatitis C virus infection among children and young people.
   J Hepatol. 2018 Nov 26. pii: S0168-8278(18)32545.
   PubMed     Text format     Abstract available
   
   
3. VAN SEYEN M, Smolders EJ, van Wijngaarden P, Drenth JPH, et al
   Successful HCV treatment of patients on contraindicated anti-epileptic drugs: Role of drug level monitoring.
   J Hepatol. 2018 Nov 22. pii: S0168-8278(18)32492.
   PubMed     Text format    
   
   
4. D'AMBROSIO R, Pasulo L, Puoti M, Vinci M, et al
   Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in 723 patients with chronic hepatitis C.
   J Hepatol. 2018 Nov 22. pii: S0168-8278(18)32543.
   PubMed     Text format     Abstract available
   
   
5. COSTA R, Todt D, Zapatero-Belinchon F, Schenk C, et al
   SEC14L2, a lipid-binding protein, regulate HCV replication in culture with inter- and intra- genotype variations.
   J Hepatol. 2018 Nov 22. pii: S0168-8278(18)32544.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

6. PIROZYAN MR, Nguyen N, Cameron B, Luciani F, et al
   Chemokine-regulated recruitment of antigen-specific T cell sub-populations to the liver in acute and chronic hepatitis C infection.
   J Infect Dis. 2018 Nov 29. pii: 5213654. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Virol

7. VELAZQUEZ-MOCTEZUMA R, Galli A, Law M, Bukh J, et al
   Hepatitis C virus escape studies for human antibody AR3A reveals a high barrier to resistance and novel insights on viral antibody evasion mechanisms.
   J Virol. 2018 Nov 28. pii: JVI.01909-18. doi: 10.1128/JVI.01909.
   PubMed     Text format     Abstract available
   
   

   
   PLoS One

8. KHAN B, Duncan I, Saad M, Schaefer D, et al
   Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment.
   PLoS One. 2018;13:e0206356.
   PubMed     Text format     Abstract available
   
   
9. BUTI M, Dominguez-Hernandez R, Casado MA, Sabater E, et al
   Healthcare value of implementing hepatitis C screening in the adult general population in Spain.
   PLoS One. 2018;13:e0208036.
   PubMed     Text format     Abstract available
   
   
10. CHOWDHURY P, Sahuc ME, Rouille Y, Riviere C, et al
    Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture.
    PLoS One. 2018;13:e0198226.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: